As the race to develop a safe and effective vaccine for COVID-19 continues, it may be difficult to understand the terminology used in news reports about the immune system and its response to viruses and vaccines. We’ve summarized some relevant information to help keep you updated on the latest COVID-19 vaccine research.
During the current pandemic, it may be difficult to keep pace with the rapid developments in tests, treatments and vaccines being studied for potential widespread use as approved technologies and therapies. You might read these news reports and wonder what is a “Phase 3 clinical trial” or an “emergency use authorization,” and why are these stages of approval by the U.S. Food and Drug Administration (FDA) important? Read on for explanations of common regulatory terms and phrases to help you understand medical research news.
Researchers at Sutter lead a national study to test whether a simple, home-based approach may prevent fractures for those with Parkinson’s disease.
Sutter participates in international HIV prevention study of cabotegravir, bringing new science to advance care at East Bay Advanced Care.
Testing is conducted to diagnose, understand and help prevent the spread of SARS-CoV-2/novel coronavirus. Follow our Educational Series on testing to stay abreast of the latest updates at Sutter. In Part 2 of this series, we describe antibody tests for SARS-CoV-2.